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The small protein ubiquitin is often linked to substrates as a polymer. Such polymers vary in 
both linkage and length, which has important consequences for their function. Surprisingly, 
the mechanisms of ubiquitin-chain assembly are still not known. Deciphering them will 
shed light on why substrates differ in the extent and timing of polyubiquitin modification 
and how ancillary ubiquitination factors function.As is true for other covalent protein modifications such 
as phosphorylation and acetylation, dynamic modifica-
tion of proteins by ubiquitin or ubiquitin-like proteins (Ubls) 
enables reversible switches between different functional 
states (Pickart and Eddins, 2004; Varshavsky, 2005). 
Ubiquitination can also irreversibly inactivate a protein by 
targeting it to the 26S proteasome for degradation. The 
nature of ubiquitin-induced functional states depends on 
whether a single ubiquitin or multiple ubiquitin molecules 
are attached to the protein. Multiple ubiquitins can be 
attached to a protein either by monoubiquitin addition to 
separate substrate sites or, more commonly, in the form of 
a polyubiquitin chain attached at a single lysine.
With the maturation of research in the ubiquitin field, 
a number of general principles have emerged about the 
enzymatic mechanisms of ubiquitin ligation to proteins. 
The discovery that ubiquitin molecules can be ligated 
to one another to form extended ubiquitin polymers on 
a protein substrate was an early milestone (Chau et al., 
1989). Ubiquitin polymers display specific amide (isopep-
tide) linkages between their ubiquitin units, which link the 
ε-amino group of a lysine of one ubiquitin to the C-termi-
nal carboxyl group of the next ubiquitin in the chain. There 
are seven different lysines in ubiquitin that can potentially 
be used for ubiquitin-chain synthesis. Proteins bearing 
Lys48-linked chains of at least four ubiquitin molecules 
are generally good substrates for degradation by the pro-
teasome (Thrower et al., 2000). Other ubiquitin-ubiquitin 
linkages have also been documented, and these different 
chain topologies correlate with different functional out-
comes. The best-studied alternative ubiquitin-chain type 
is the Lys63-linked chain. Attachment to such chains acti-
vates specific proteins for DNA repair, signal transduc-
tion, and endocytosis, among other functions, but Lys63-
linked polyubiquitin-protein conjugates are not targeted 
by the proteasome (Pickart and Fushman, 2004; Sun and 
Chen, 2004).
All this is fairly well established, as is the identity of the 
enzymatic machinery responsible for attaching ubiquitin 
to various protein substrates. The now well-known E1-E2-E3 trio of enzymes is responsible for activating and 
transferring ubiquitin to proteins (see Figure 1). Addition-
ally, many high-resolution three-dimensional structures of 
different E2 and E3 enzymes have been determined, and 
these have yielded many insights into the mechanisms 
of ubiquitin-protein attachment. However, despite these 
advances, and contrary to most textbook depictions, the 
fundamental mechanism(s) of ubiquitin-chain assembly 
remains unknown. The textbook version—which has not 
been proven incorrect—holds that ubiquitin molecules 
are added one at a time, first to the substrate protein and 
then to the distal end of the growing ubiquitin chain. This 
“sequential addition model” is outlined in Figure 2A.
In this brief review, I will discuss variations of this 
model that have been proposed in recent years, and I will 
also outline more radical departures from the standard 
sequential addition model. In truth, there are few published 
results that allow a clear choice between these different 
schemes. Deciphering the exact mechanisms of ubiquitin-
chain assembly will be necessary for understanding many 
key features of protein ubiquitination, such as the appar-
ent processivity of protein polyubiquitination, the activity 
of so-called chain elongation factors, and the shielding of 
polyubiquitin-protein conjugates from premature deubiq-
uitination by cellular deubiquitinating enzymes (DUBs).
The Molecular Players in Ubiquitin-Chain 
 Assembly and Disassembly
Attachment of ubiquitin to substrate proteins involves sev-
eral enzymatic steps (Pickart and Eddins, 2004) (Figure 
1). The C terminus of ubiquitin is first activated by ubiq-
uitin-activating enzyme (E1). Through an ATP-dependent 
mechanism, ubiquitin is coupled to a cysteine side chain in 
E1, yielding a reactive E1~ubiquitin thioester intermediate. 
The activated ubiquitin is subsequently passed to one of 
a number of distinct ubiquitin-conjugating enzymes (E2s) 
by transthiolation to a conserved cysteine of the E2. The 
E2 proteins catalyze substrate ubiquitination in conjunc-
tion with a ubiquitin-protein ligase (E3). For one structural 
class of E3 proteins (the “HECT” E3s), the ubiquitin is first Cell 124, January 13, 2006 ©2006 Elsevier Inc. 27
transferred to a conserved cysteine of the E3 before the 
final transfer to a substrate group (usually a lysine side 
chain; Figure 1). For most other ubiquitination reactions, 
the E3 appears to function as an adaptor that positions 
the substrate in close proximity to the reactive E2~ubiquitin 
thioester bond. The majority of such E3s have a subunit or 
domain bearing a RING motif.
In addition to substrate recognition, other roles for E3s 
in the catalytic cycle, such as allosteric activation of the 
E2, remain a distinct possibility (Wu et al., 2003; Pick-
Figure 1. Outline of the Ubiquitin-Conjugation Pathway
Activation of the ubiquitin C terminus by E1 proceeds in two steps: ade-
nylation (not shown) followed by attack by a cysteine side chain to form a 
thioester bond between the E1 and ubiquitin. Ubiquitin is then passed to 
a cysteine of an E2. Ligation of the ubiquitin to a substrate (S), usually to 
a lysine side chain, follows either directly with the aid of a RING-bearing 
E3 or after an intermediate transthiolation to a cysteine side chain of a 
HECT-domain E3. Both types of E3 interact with their substrates, many 
of which acquire a polyubiquitin chain rather than just a single ubiquitin. 
Note: The dashed red arrows represent the direction of movement of 
ubiquitin, not the direction of nucleophilic attack.28 Cell 124, January 13, 2006 ©2006 Elsevier Inc.art and Eddins, 2004). All E2s have an asparagine resi-
due upstream of the active-site cysteine. This asparagine 
appears to help form the oxyanion hole that stabilizes the 
tetrahedral intermediate resulting from nucleophilic sub-
strate attack on the activated ubiquitin carbonyl (Wu et al., 
2003). However, in the atomic structures of isolated E2 
enzymes, the side chain of the asparagine is fully hydro-
gen bonded and oriented away from the active cysteine. 
E3 binding to the E2 or ubiquitin thioester formation on 
the E2 (or both) might trigger local structural changes that 
allow movement of the E2 asparagine side chain to a posi-
tion where it can help generate a functional oxyanion hole 
(Reverter and Lima, 2005).
Not to be forgotten are the DUBs. These enzymes have 
a major impact on cellular amounts of polyubiquitin chains, 
both those that are attached to specific proteins and those 
that are apparently unanchored or “free.” The mechanistic 
characteristics of chain assembly, such as the degree of 
processivity, will influence the susceptibility of ubiquitin-
modified proteins to deubiquitination. There are at least 
five different structural classes of DUBs, and a wide range 
of substrate specificities and functions have been reported 
(Amerik and Hochstrasser, 2004; Nijman et al., 2005).
Coupling Ubiquitin Binding Sites for Ubiquitin-
Chain Assembly
When considering mechanisms of chain assembly, it 
is important to bear in mind that substrates are often 
adorned with very long ubiquitin polymers, sometimes 
containing over a dozen ubiquitin molecules (Varshavsky, 
2005). Another relevant fact is that free ubiquitin chains 
can be synthesized by some E2s without the aid of an E3. 
The earliest and most studied example is E2-25K, a mam-
malian E2 capable of assembling Lys48-ubiquitin chains 
(Chen et al., 1991). Interestingly, E2-25K from mammals 
and Ubc1 from yeast include C-terminal domains related 
in structure to the UBA domain, which forms a three-helix 
bundle that binds ubiquitin (Merkley et al., 2005). In nei-
ther case is the UBA domain required for free polyubiqui-
tin-chain synthesis; however, deletion of the UBA of Ubc1 
alters the length and ubiquitin-ubiquitin linkage specificity 
of the chain (Pichler et al., 2005; Merkley et al., 2005). 
Thus, noncovalent binding of a second ubiquitin molecule 
to a separate site in the E2 might dictate certain features of 
ubiquitin-chain assembly. In other pathways, the E3 might 
provide this additional noncovalent ubiquitin binding site. 
This could place a second ubiquitin molecule near the 
ubiquitin~E2 thioester in a way that facilitates their linkage. 
Another way to juxtapose a pair of ubiquitin molecules for 
ubiquitin-ubiquitin formation might be through dimeriza-
tion of E2s (Silver et al., 1992; Chen et al., 1993; Gazdoiu 
et al., 2005). Most E2s behave in vitro as monomers, but 
both in vitro and in vivo analyses have suggested an abil-
ity to form dimers, particularly if the E2 is charged with 
ubiquitin. For the synthesis of Lys48-ubiquitin chains in 
vivo, E2 homodimers and heterodimers may be important 
in particular ubiquitination pathways. Homodimerization 
of the Cdc34 E2 is induced by ubiquitin thioester forma-
tion and is necessary for its function (Varelas et al., 2003), 
and heterodimer formation between the Ubc6 and Ubc7 
E2s was suggested by yeast two-hybrid analysis (Chen 
et al., 1993).
Perhaps the clearest data on the initiation of ubiquitin-
chain assembly comes from the structural analysis of the 
heterodimer formed between Ubc13 and UEV (ubiquitin-E2 
variant) proteins, which specifically catalyzes Lys63-linked 
ubiquitin-chain synthesis (Pickart and Eddins, 2004). The 
UEV proteins have the same overall tertiary structure as 
active E2 enzymes, but they lack the catalytic cysteine. 
Instead, the UEV protein positions a second ubiquitin mol-
ecule noncovalently in the Ubc13-UEV heterodimer such 
that Lys63 of the noncovalently bound ubiquitin can attack 
the thioester-linked ubiquitin on Ubc13. The structural data 
can neatly explain the topological specificity of ubiquitin 
dimer assembly by Ubc13-UEV heterodimers but do not 
clarify how longer chains are made.
Another significant point to consider in relation to ubiq-
uitin-chain assembly mechanisms is the discovery that E1 
and E3 binding sites on the E2 overlap, and their binding 
to E2 is mutually exclusive (Eletr et al., 2005). Therefore, if 
ubiquitin chains are assembled on substrates by a sequen-
tial addition mechanism, multiple cycles of E2-E3 binding 
and release are probably necessary. Potentially, if a stable 
E2 dimer is present in the E2-E3 complex, full release of 
the E3 from the E2 might be avoided if E1 and E3 bind to 
different E2 monomers in the dimer. Other mechanisms 
of ubiquitin-chain synthesis might also require cyclical 
release of E2 from E3 (see below).
Who’s on First: Models for Ubiquitin-Chain 
Assembly
The sequential addition model (the standard model) for 
chain assembly is a logical extension of a monoubiqui-
tination reaction in which a substrate lysine attacks the 
ubiquitin~E2 (or ubiquitin~HECT E3) thioester bond (see 
Figure 2A). In each ensuing cycle, the ubiquitin most dis-
tal in the chain from the substrate provides the attacking 
lysine. This model becomes less intuitively appealing when 
applied to substrates with long ubiquitin chains because 
the attacking ubiquitin group becomes structurally remote 
from the original substrate protein bound to E3. This could 
be accommodated by looping out the growing ubiquitin 
chain between the substrate and E2 binding sites on the 
E3. Because E1 and E3 binding to an E2 appears to be 
mutually exclusive, such looping would need to be re-
established in each ubiquitin addition cycle if continuous 
E3-substrate binding is required for processive ubiquitina-
tion (Reiss et al., 1989; Rape et al., 2006).
Several variations of the sequential addition model 
have been put forward. One idea, called the “hit-and-
run” hypothesis, proposes that the ubiquitin~E2 thioester 
dissociates from the E3 and diffuses to the distal end of 
the growing ubiquitin chain, where ubiquitin transfer then 
occurs (Deffenbaugh et al., 2003). This model is based on 
the observation that the E2 (Cdc34) must be released from 
the E3 (SCFCdc4) for efficient substrate polyubiquitination. However, this requirement might simply reflect the compe-
tition between E1 and E3 for overlapping binding sites on 
the E2. On the other hand, if the E3 triggers an activating 
conformational change in the ubiquitin~E2 complex prior 
to release, the hit-and-run model could still potentially 
explain how an E3 stimulates polyubiquitin-chain exten-
sion on a substrate. The Lys48 linkage specificity of these 
chains would have to derive from an intrinsic property of 
the Cdc34 E2.
Another hypothesis that has been proposed to help 
explain the synthesis of long ubiquitin chains in the context 
of the sequential addition model invokes chain elonga-
tion factors (sometimes called “E4s”) (Koegl et al., 1999). 
These elongation factors still require an E3 of the HECT 
class for chain assembly. Although the exact mechanism 
by which they enhance long ubiquitin-chain assembly 
remains obscure, the proteins proposed to be E4s can 
themselves function as E3s in other assays (Hatakeyama 
et al., 2001). The E4 proteins contain a U box motif, which 
turns out to have a tertiary structure very similar to that of 
the RING domain (Ohi et al., 2003). It is therefore plausi-
ble that E4 elongation factors are actually E3s that can 
use the ubiquitin thioester-linked HECT domain of their 
cognate E3s in much the same way that other E3s use 
a cognate ubiquitin~E2 thioester for chain elongation. As 
will be discussed below, chain “elongation factors” can be 
incorporated into other chain-assembly models as well.
What are the alternatives to the sequential addition 
model? Surprisingly few explicit discussions of polyubiq-
uitin-chain-assembly mechanisms exist in the literature. 
The few exceptions usually only consider formation of the 
first ubiquitin-ubiquitin bond, which allows the more com-
plicated gymnastics of long ubiquitin-chain synthesis to be 
side-stepped. One early idea, developed from the finding 
that unanchored ubiquitin chains can be synthesized de 
novo and can serve as donors for transfer to a (nonubiqui-
tin) substrate (Chen et al., 1991; Van Nocker and Vierstra, 
1993), was that ubiquitin chains could be plucked from 
solution by an E1, and the available C-terminal carboxyl 
group at the base of the chain could then be activated and 
conjugated to a substrate. Most cell types have significant 
amounts of what appear to be “free” ubiquitin chains, 
so this idea is not entirely implausible (Van Nocker and 
 Vierstra, 1993).
Noel and colleagues recently proposed an “indexation 
model” for ubiquitin-chain synthesis (Verdecia et al., 2003). 
Although highly speculative, this model was the first to 
address how a longer ubiquitin chain might be built on an 
enzyme active site prior to direct transfer to a substrate 
lysine (see Figure 2B). The model was inspired by the 
observation that in HECT E3s, the HECT domain has two 
lobes connected by a flexible linker; flexibility in this hinge is 
essential for E3 activity. In the indexation model, sequential 
transfer of ubiquitin units from the E2 active site to the distal 
end of a ubiquitin chain tethered to the E3 cysteine would 
be marked by a progressive opening of the hinge between 
the two HECT domain lobes. A length limit to the chain is 
implied by this mechanism, and once a ubiquitin tetramer Cell 124, January 13, 2006 ©2006 Elsevier Inc. 29
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formed on the HECT active site, it was proposed that a 
substrate lysine would attack the thioester and acquire the 
ubiquitin chain. The existing literature, however, offers no 
evidence for such a chain length limit.
Alternatives to both the sequential addition and indexa-
tion models can be proposed. In what I will call the “see-
saw model,” a polyubiquitin chain is also assembled by a 
pair of active sites prior to transfer to substrate; these sites 
are assumed to arise from an E2 dimer, although an E2-
HECT domain pairing is also possible (see Figure 2C). The 
ubiquitin chain is built by a back-and-forth transfer of the 
growing ubiquitin chain from one active-site cysteine to the 
other. Chain transfer (as shown in Figure 2C) is caused by 
nucleophilic attack on the thioester-linked carbonyl of one 
ubiquitin by a lysine side chain of the other thioester-linked 
ubiquitin. Another possible step in the cycle (not depicted 
in Figure 2C) would be a transfer of the extended ubiquitin 
chain back to the other E2 cysteine by transthiolation. This 
would mean that only a single E2 in the dimer is charged 
by the E1 in all the ubiquitin addition cycles. At some point, 
a substrate lysine will attack the thioester at the base of 
the chain, resulting in substrate polyubiquitination. If sub-
strate bound E3 specifically stimulated the ubiquitin-chain-
forming activity of the E2, then ubiquitin chains would be 
assembled preferentially when a substrate is available for 
subsequent modification by the chain. This might also limit 
E2 autoubiquitination and inactivation.
The seesaw and indexation mechanisms differ in sev-
eral key regards. First and most importantly, in the see-
saw mechanism, the latest ubiquitin added is always at 
the base of the chain rather than the distal end. Second, 
there is no obvious length limit imposed by this mecha-
nism. Finally, if the ubiquitin chain is not returned to one 
of the E2s by transthiolation in each ubiquitin addition 
cycle, then E1 must alternate between charging differ-
ent E2 monomers with ubiquitin, whereas in the indexa-
tion model, a single E2 suffices. (If an E2-HECT E3 dimer 
were the basis of the seesaw mechanism, either another 
E2 would be needed to charge the E3 or the ubiquitin 
chain would have to be moved by transthiolation to the 
E3 cysteine in each cycle.) Of all the models discussed in 
Figure 2, only the seesaw mechanism always places the 
most recently added ubiquitin at the base of the chain, a 
feature that can be tested experimentally.A final model to consider here is the “hybrid model” dia-
grammed in Figure 2D. In this scheme, a second, non-
covalent ubiquitin binding site is supplied by an E2, E3, or 
another protein. The model is a hybrid because, as in the 
sequential addition mechanism, the noncovalent ubiqui-
tin binding site is acting much like a RING E3 to position 
substrate—in this case ubiquitin—to facilitate nucleophilic 
attack on the ubiquitin~E2 thioester, but, as in the indexa-
tion/seesaw models, the polyubiquitin chain is linked to 
an enzyme active site prior to transfer to substrate. Cycles 
of ubiquitin-chain release and rebinding might be nec-
essary for chain synthesis by this mechanism. Several 
results can be cited in support of the hybrid model. As 
noted earlier, ubiquitin-chain assembly by Ubc13-UEV 
heterodimers involves the positioning of a noncovalently 
bound ubiquitin for attack on a thioester-linked ubiquitin. 
The ubiquitin binding UBA domains of E2s such as E2-
25K and Ubc1, though not necessary for ubiquitin-chain 
elongation, might function in the switch that moves the 
ubiquitin chain onto the E1 active-site cysteine (Figure 2D), 
from which the chain can be transferred to the E2 and 
then substrate. Some E3s also include ubiquitin binding 
domains, although their functional significance for polyu-
biquitin-chain synthesis is not certain.
Are there any experimental findings that lend credence 
to any of these alternative models? The answer, at present, 
is very few. However, in a study just published, Wang and 
Pickart (2005) provide the first experimental evidence for 
ubiquitin-ubiquitin bond formation between two ubiqui-
tin molecules that must both be in thioester linkage to an 
active-site cysteine. When E6-AP, a monomeric HECT-class 
E3, carries a ubiquitin on its active-site cysteine, Lys48 of 
this ubiquitin attacks the ubiquitin thioester bond on the 
cognate E2. Assembly of a thioester-linked ubiquitin dimer 
on the HECT E3 is the same in the indexation and see-
saw models, so distinguishing between these models will 
require analysis of longer ubiquitin chains. Unfortunately, 
E6-AP is inefficient in vitro at synthesizing chains with more 
than two ubiquitin moieties. Another interesting finding from 
this same study is that another HECT E3, KIAA10, uses 
a different mechanism of chain synthesis, which is most 
consistent with the sequential addition or hybrid model. 
Therefore, different E3s can utilize different mechanisms of 
polyubiquitin-chain assembly, at least in vitro.Figure 2. Models for Polyubiquitin-Chain Synthesis
(A) Sequential addition model (the “standard model”), in which ubiquitin molecules are added one at a time, first to a lysine on the substrate protein (S) and 
then to a specific lysine in the ubiquitin at the distal end of the growing ubiquitin chain. A RING E3 is depicted and is assumed to remain associated with 
the substrate through multiple rounds of ubiquitin addition.
(B) Indexation model (Verdecia et al., 2003). The ubiquitin chain is first built on the active-site cysteine in the HECT domain of the E3 ligase before ultimately 
being transferred to the substrate. A flexible hinge between two lobes of the HECT domain (not depicted) allows repositioning of the ubiquitin chain such 
that a lysine in the distal end of the chain is oriented for attack on the E2~ubiquitin thioester. The chain is “indexed” to a limited length because of the 
physical constraints imposed by the E3 structure.
(C) Seesaw model. Ubiquitin chains are built by a pair of E2s (either a homo- or heterodimer), which pass the growing chain back and forth between the 
two E2 active sites, before being transferred to the substrate. During chain assembly, the attacking lysine is always on a monomeric ubiquitin that is in 
thioester linkage to an E2. An E3 HECT domain could replace one of the E2s in this model. The order of ubiquitin addition is opposite to that in the other 
three models (compare colors).
(D) Hybrid model. The ubiquitin chain is assembled prior to transfer to the substrate, but a noncovalent interaction between (poly)ubiquitin and a site in the 
E2 or E3 (the latter is depicted) positions it for nucleophilic attack on the E2~ubiquitin thioester, much as in the sequential addition model. At some point, 
the free end of the ubiquitin chain must be activated by E1 and transferred to the E2 cysteine before the final transfer of the chain to the substrate.Cell 124, January 13, 2006 ©2006 Elsevier Inc. 31
Implications of Different Chain-Assembly Models
How might these alternative ubiquitin-chain-assembly 
mechanisms impact our understanding of other features 
of ubiquitin-protein conjugation? One important parameter 
of protein polyubiquitination is the processivity of ubiqui-
tin-chain formation (the number of ubiquitin molecules 
attached in one binding event to the E3). A more distribu-
tive mechanism of ubiquitin-chain assembly, where the 
ubiquitinated substrate intermediates dissociate from and 
must rebind the E3, presumably both limits the rate of long-
chain assembly and exposes the chains to disassembly 
by DUBs. By the sequential addition model, slower dis-
sociation of a substrate from an E3 would enhance long-
ubiquitin-chain assembly by increasing the probability of 
further ubiquitin additions before substrate dissociation. In 
contrast, by the models involving preassembly of ubiquitin 
chains on the E2 or E2-E3 complex, apparent processivity 
could be enhanced if nucleophilic attack by the substrate 
were delayed; this would allow further rounds of ubiquitin-
chain extension before transfer to the substrate. One impli-
cation of this reasoning is that two substrates with similar 
dissociation rates from an E3 might nonetheless have dif-
ferent propensities to form long ubiquitin chains because 
of structural differences that control substrate attack on 
the polyubiquitin~enzyme thioester. If their conjugate forms 
were targets of the proteasome, these substrates could 
have very different half-lives.
An elegant study in this issue of Cell (Rape et al., 2006) 
suggests that the degree of processivity in ubiquitin-chain 
assembly is substrate specific and can be exploited by 
the cell to dictate the temporal sequence in which mul-
tiple substrates of the same E3 are degraded. The E3 in 
this case is the anaphase-promoting complex (APC), a 
multisubunit complex with a RING-bearing subunit, which 
promotes the sequential degradation of several key cell-
cycle regulators during mitosis and G1. Highly proces-
sive substrates acquire long ubiquitin chains in vitro at 
the expense of more distributive substrates, which require 
multiple APC binding events for long-chain acquisition 
and are susceptible to deubiquitination. Notably, the tem-
poral sequence in which APC substrates are degraded in 
vivo correlates with the relative processivity of their polyu-
biquitination by the APC.
Are these new data compatible with preassembly 
of ubiquitin chains or only with the sequential addition 
model? The authors argue in favor of the latter mecha-
nism because they observed a gradual increase in polyu-
biquitin-protein conjugate size with time when a distribu-
tive substrate was analyzed, which seems contrary to the 
transfer of a single preassembled chain. Also, when they 
monitored single APC binding events with such a sub-
strate, only a few ubiquitins were added to different sub-
strate lysines, rather than polyubiquitin chains (Rape et 
al., 2006). However, if apparent processivity is enhanced, 
as just discussed, by limiting the rate of ubiquitin transfer 
from the E2-E3 complex to substrate relative to the rate 
of assembly of a preformed chain on the E2, then these 
observations are in accord with what would be expected 32 Cell 124, January 13, 2006 ©2006 Elsevier Inc.for a distributive substrate bearing multiple lysine tar-
gets. Preincubation of E1, E2, E3, and ubiquitin prior 
to substrate addition also did not enhance subsequent 
polyubiquitination of the substrate, as might have been 
expected if chains were preassembled on the E2 (Rape 
et al., 2006). However, this result could also be accounted 
for if substrate binding to the E3 was necessary for stim-
ulating ubiquitin-chain synthesis on the cognate E2, as 
suggested above, or if the E2 was autoubiquitinated and 
inactivated during the preincubation. The point is not that 
the sequential addition mechanism does not operate 
here, but rather that determining a particular chain-syn-
thesis mechanism will generally require assays that spe-
cifically distinguish among the different mechanisms. In 
fact, an interesting possibility would be that “distributive” 
substrates are polyubiquitinated by a sequential addition 
mechanism, whereas “processive” substrates are able to 
engage the APC-E2 complex in a way that allows a more 
efficient preassembled chain-transfer mechanism.
Ubiquitin-chain synthesis was also addressed in 
another recent study, in this case using the in vitro system 
based on the SCFCdc4 E3 and Cdc34 E2 (Petroski and 
Deshaies, 2005). These authors reported that the attach-
ment of the first ubiquitin to a substrate appears to be rate 
limiting for substrate polyubiquitination. The most direct 
evidence for this came from a comparison of an already 
monoubiquitinated substrate to the unmodified version of 
the same protein: the former is polyubiquitinated much 
more quickly than the latter. When looking at unmodified 
substrate, E3 stimulates both mono- and polyubiquitina-
tion with comparably slow kinetics. These results were 
interpreted in terms of the sequential addition model, in 
which the slow step in substrate polyubiquitination was 
the attachment of the first ubiquitin followed by rapid 
serial extension of the polyubiquitin chain. If one were 
to look at these data from the vantage of ubiquitin-chain 
preassembly, a slightly different interpretation could be 
proposed. The similar kinetics of monoubiquitination and 
polyubiquitination are consistent with an equally prob-
able transfer of either a single ubiquitin or a preformed 
ubiquitin chain to the substrate. Provision of an already 
monoubiquitinated substrate simply creates a different 
substrate, and preassembled chains might preferentially 
transfer to such a substrate.
Chain elongation factors (E4s) can also be viewed in a 
different light if chain assembly proceeds through a see-
saw or indexation mechanism. An E4 might function by 
altering the E2-E2 or E3-E2 complex, for example, to limit 
ubiquitin-chain hydrolysis from the active site or to accom-
modate a longer ubiquitin chain, so that longer ubiquitin 
chains are favored. Alternatively, an E4 might act as a 
processivity factor by decreasing the rate of whole-chain 
transfer to substrate relative to the rate of chain elonga-
tion on the E2 or E3. In a similar vein, the function of an E3 
might include organizing or stabilizing an E2 dimer or E2-
HECT domain interaction in a way that facilitates ubiqui-
tin-chain elongation at the active sites of these enzymes. 
A recently solved crystal structure of an E2-E3 complex 
with a bound Ubl-substrate conjugate indeed suggests 
such a role for the E3 in correctly orienting a charged E2 
(Reverter and Lima, 2005).
Another potential consequence of assembling long ubiq-
uitin chains on an E2 or E3 active site is the opportunity for 
self-regulation by autoubiquitination (and proteasomal deg-
radation). Autoubiquitination of E2s has in several instances 
been shown to depend on the active-site cysteine, and the 
E2 cannot be polyubiquitinated in trans by another, active 
version of the same E2 (Rape and Kirschner, 2004; Walter 
et al., 2001). The detected polyubiquitin chains on the E2 
were lysine linked, but it is conceivable that a polyubiqui-
tin chain on the E2 active-site cysteine could also target 
the protein to the proteasome. For UbcH10, a cell-cycle-
regulated E2 that functions with the APC E3, autoubiquiti-
nation only occurs after other APC substrates have been 
ubiquitinated and degraded in early G1 phase (Rape and 
Kirschner, 2004). Degradation of UbcH10 is needed for the 
subsequent entry of cells into S phase.
Concluding Remarks
Although multiple E2 and E3 enzyme structures have now 
been determined, it is becoming apparent that many of 
these structures, particularly those of E2-E3 complexes, 
may be in conformations or arrangements that do not reflect 
the catalytically active state. For example, the distance 
between the E2 and E3 active-site cysteines observed 
in the UbcH7-E6-AP crystal structure is over 40 Å, even 
though ubiquitin transfer between these sites requires that 
they come within a few Ångstroms of one another (Huang 
et al., 1999). A full understanding of how these E2-E3 
complexes function will require that we figure out what the 
active subunit arrangements are (for example, must the 
complexes or at least the E2 components dimerize?) and 
by what mechanism polyubiquitin chains are assembled. 
This in turn will depend on well-defined in vitro systems for 
biochemical and kinetic studies. The first stirrings of work 
in this direction are emerging, and we should soon see the 
types of mechanistic models for ubiquitin-chain assembly 
outlined here put to rigorous test.
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